Company intelligence / Profile preview

Trustar Capital

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Trustar Capital (formerly known as CITIC Capital Partners) is a leading private equity firm and an affiliate of CITIC Capital Holdings Limited. Headquartered in Hong Kong, the firm focuses on control buyout opportunities globally, particularly in companies that can capitalize on the growth and productivity of the Chinese economy. Trustar Capital has a significant investment footprint in the healthcare and life sciences sectors, with a portfolio that includes Harbin Pharmaceutical Group, GNC, Taibang Biologic Group, Jissbon, Genertec Universal Medical, Hygeia Healthcare, Genesis MedTech, MedAlliance, and Guilong Pharmaceutical. The firm manages billions in committed capital across multiple funds, driving value creation through strategic M&A and operational integration.

Industry: Investors

Beyond the preview

Go deeper on Trustar Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trustar Capital.

Explore the full profile